229 related articles for article (PubMed ID: 17586848)
1. Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia.
Lavin MF; Gueven N; Bottle S; Gatti RA
Br Med Bull; 2007; 81-82():129-47. PubMed ID: 17586848
[TBL] [Abstract][Full Text] [Related]
2. The ATM gene and ataxia telangiectasia.
Mavrou A; Tsangaris GT; Roma E; Kolialexi A
Anticancer Res; 2008; 28(1B):401-5. PubMed ID: 18383876
[TBL] [Abstract][Full Text] [Related]
3. [Ataxia-telangiectasia: a review].
Bott L; Thumerelle C; Cuvellier JC; Deschildre A; Vallée L; Sardet A
Arch Pediatr; 2006 Mar; 13(3):293-8. PubMed ID: 16423518
[TBL] [Abstract][Full Text] [Related]
4. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer.
Lavin MF
Nat Rev Mol Cell Biol; 2008 Oct; 9(10):759-69. PubMed ID: 18813293
[TBL] [Abstract][Full Text] [Related]
5. Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.
Micol R; Ben Slama L; Suarez F; Le Mignot L; Beauté J; Mahlaoui N; Dubois d'Enghien C; Laugé A; Hall J; Couturier J; Vallée L; Delobel B; Rivier F; Nguyen K; Billette de Villemeur T; Stephan JL; Bordigoni P; Bertrand Y; Aladjidi N; Pedespan JM; Thomas C; Pellier I; Koenig M; Hermine O; Picard C; Moshous D; Neven B; Lanternier F; Blanche S; Tardieu M; Debré M; Fischer A; Stoppa-Lyonnet D;
J Allergy Clin Immunol; 2011 Aug; 128(2):382-9.e1. PubMed ID: 21665257
[TBL] [Abstract][Full Text] [Related]
6. [From gene to disease; ataxia telangiectasia].
Broeks A; van 't Veer LJ; Ottenheim C; Hiel JA; Kleijer WJ; Weemaes C
Ned Tijdschr Geneeskd; 2003 Mar; 147(9):386-9. PubMed ID: 12661456
[TBL] [Abstract][Full Text] [Related]
7. Different clinical and immunological presentation of ataxia-telangiectasia within the same family.
Soresina A; Meini A; Lougaris V; Cattaneo G; Pellegrino S; Piane M; Darra F; Plebani A
Neuropediatrics; 2008 Feb; 39(1):43-5. PubMed ID: 18504682
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow transplantation improves the outcome of Atm-deficient mice through the migration of ATM-competent cells.
Pietzner J; Baer PC; Duecker RP; Merscher MB; Satzger-Prodinger C; Bechmann I; Wietelmann A; Del Turco D; Doering C; Kuci S; Bader P; Schirmer S; Zielen S; Schubert R
Hum Mol Genet; 2013 Feb; 22(3):493-507. PubMed ID: 23100326
[TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis, diagnosis, clinical and therapeutic aspects of ataxia telangiectasia].
Güngör T; Bühring I; Cremer R; Gartenschläger M; Zielen S
Klin Padiatr; 1997; 209(5):328-35. PubMed ID: 9411043
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic ATM protein kinase: an emerging therapeutic target for diabetes, cancer and neuronal degeneration.
Yang DQ; Halaby MJ; Li Y; Hibma JC; Burn P
Drug Discov Today; 2011 Apr; 16(7-8):332-8. PubMed ID: 21315178
[TBL] [Abstract][Full Text] [Related]
11. [Ataxia telangiectasia].
Hosoi H; Sawada T
Nihon Rinsho; 2000 Jul; 58(7):1505-10. PubMed ID: 10921332
[TBL] [Abstract][Full Text] [Related]
12. [Cellular repair potential in families of ataxia-telangiectasia patients].
Polubotko EA; Shatrova AN; Pleskach NM; Mikhel'son VM; Spivak IM
Tsitologiia; 2009; 51(12):978-85. PubMed ID: 20141033
[TBL] [Abstract][Full Text] [Related]
13. The many substrates and functions of ATM.
Kastan MB; Lim DS
Nat Rev Mol Cell Biol; 2000 Dec; 1(3):179-86. PubMed ID: 11252893
[TBL] [Abstract][Full Text] [Related]
14. DNA damage-induced signalling in ataxia-telangiectasia and related syndromes.
Lavin MF; Kozlov S
Radiother Oncol; 2007 Jun; 83(3):231-7. PubMed ID: 17512070
[TBL] [Abstract][Full Text] [Related]
15. ATM mutations, haplotype analysis, and immunological status of Russian patients with ataxia telangiectasia.
Birrell GW; Kneebone K; Nefedov M; Nefedova E; Jartsev MN; Mitsui M; Gatti RA; Lavin MF
Hum Mutat; 2005 Jun; 25(6):593. PubMed ID: 15880721
[TBL] [Abstract][Full Text] [Related]
16. Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress?
Rotman G; Shiloh Y
Bioessays; 1997 Oct; 19(10):911-7. PubMed ID: 9363685
[TBL] [Abstract][Full Text] [Related]
17. The role of ATM in DNA damage responses and cancer.
Canman CE; Lim DS
Oncogene; 1998 Dec; 17(25):3301-8. PubMed ID: 9916992
[TBL] [Abstract][Full Text] [Related]
18. Role for ATM in DNA damage-induced phosphorylation of BRCA1.
Gatei M; Scott SP; Filippovitch I; Soronika N; Lavin MF; Weber B; Khanna KK
Cancer Res; 2000 Jun; 60(12):3299-304. PubMed ID: 10866324
[TBL] [Abstract][Full Text] [Related]
19. Papillary thyroid carcinoma in a 9-year-old girl with ataxia-telangiectasia.
Brasseur B; Beauloye V; Chantrain C; Daumerie C; Vermylen C; Waignein F; Brichard B
Pediatr Blood Cancer; 2008 May; 50(5):1058-60. PubMed ID: 16917912
[TBL] [Abstract][Full Text] [Related]
20. Dramatic extension of tumor latency and correction of neurobehavioral phenotype in Atm-mutant mice with a nitroxide antioxidant.
Gueven N; Luff J; Peng C; Hosokawa K; Bottle SE; Lavin MF
Free Radic Biol Med; 2006 Sep; 41(6):992-1000. PubMed ID: 16934683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
